Tentt

Kezar Life Sciences Acquired by Aurinia Pharma U.S. | Pharmaceuticals M&A Deal

Closed
PharmaceuticalsDelawareMerger

Deal Summary

Aurinia Pharma U.S. completed the acquisition of Kezar Life Sciences via a merger, making Kezar a wholly owned subsidiary.

Key Details

Transaction
Aurinia Pharma U.S. acquires Kezar Life Sciences
Reported Value
$0.001

Filed under

Source

Read full article on sec.gov

via SEC EDGAR — SC TO · May 11, 2026

Powered by Tentt

Source pharmaceuticals deals in Delaware for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Pharmaceuticals deals →See all deals in Delaware →